oa SA Pharmaceutical Journal - Drug info - new product focus
|Article Title||Drug info - new product focus|
|© Publisher:||Medpharm Publications|
|Journal||SA Pharmaceutical Journal|
|Publication Date||Apr 2010|
Byetta® has been approved for use as adjunctive therapy to improve glycaemic control in patients with type 2 diabetes mellitus who are taking either metformin or a sulphonylurea or both, and who have not achieved glycaemic control.
Article metrics loading...